Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.36p
   
  • Change Today:
      0.035p
  • 52 Week High: 4.53
  • 52 Week Low: 1.32
  • Currency: UK Pounds
  • Shares Issued: 624.90m
  • Volume: 29,535,365
  • Market Cap: £8.50m
  • RiskGrade: 747
  • Beta: 0.01

Latest ShareCast News

Genedrive secures CE certification for CYP2C19 ID Kit

By Josh White

Date: Friday 30 May 2025

(Sharecast News) - Genedrive announced on Friday that it has secured CE certification for its CYP2C19 ID Kit under the European In Vitro Diagnostic Regulation (IVDR), allowing the pharmacogenetic test to be marketed and used across the EU and in certain non-European countries that recognise CE-IVD marking.

Genedrive upbeat on publication of clinical performance data

By Josh White

Date: Friday 27 Dec 2024

(Sharecast News) - Point-of-care pharmacogenetic testing specialist Genedrive announced on Friday that clinical performance data for its Genedrive CYP2C19-ID Kit had been published in the Journal of Molecular Biology.

Genedrive full-year revenue rises

By Josh White

Date: Friday 29 Nov 2024

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive reported a significant increase in revenue in its full-year results on Friday.

Director dealings: Genedrive chairman snaps up s... 15-Aug-2024 ShareCast
Genedrive makes first commercial sales of CYP2C1... 12-Aug-2024 ShareCast
Genedrive test ordered by five Manchester area h... 24-May-2024 ShareCast
Genedrive shares jump on NICE test recommendation 03-Apr-2024 ShareCast
Genedrive receives R&D tax credit, plans fundraise 15-Mar-2024 ShareCast
Genedrive set to apply for NICE EVA funding 19-Feb-2024 ShareCast
Genedrive confirms £0.6m equity prepayment drawd... 02-Jan-2024 ShareCast
Genedrive gets first product orders from several... 20-Dec-2023 ShareCast
Genedrive diagnostic test system gets UKCA regis... 06-Sep-2023 ShareCast
Genedrive draws down £0.3m under equity prepayme... 05-Jul-2023 ShareCast
Genedrive secures multi-partner grant award 16-Jun-2023 ShareCast
Genedrive jumps on draft NICE testing guidance 19-May-2023 ShareCast
Genedrive engages with US FDA over infant test 05-Oct-2022 ShareCast
Genedrive test to go through new, faster NICE pr... 26-Sep-2022 ShareCast
Another Genedrive test to be assessed by NICE 22-Aug-2022 ShareCast
Genedrive test to be evaluated by NICE 16-Jun-2022 ShareCast
Genedrive rallies on positive news about hearing... 29-Mar-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 1.36p
Change Today 0.035p
% Change 2.64 %
52 Week High 4.53
52 Week Low 1.32
Volume 29,535,365
Shares Issued 624.90m
Market Cap £8.50m
Beta 0.01
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.9% below the market average16.9% below the market average16.9% below the market average16.9% below the market average16.9% below the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average
Price Trend
70.33% below the market average70.33% below the market average70.33% below the market average70.33% below the market average70.33% below the market average
56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average56.76% below the sector average
Income Not Available
Growth
68.00% above the market average68.00% above the market average68.00% above the market average68.00% above the market average68.00% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average

Genedrive Dividends

No dividends found

Trades for 30-May-2025

Time Volume / Share Price
17:06 415,442 @ 1.36p
16:28 24,612 @ 1.37p
16:28 30,000 @ 1.37p
16:23 100,000 @ 1.34p
16:12 150,000 @ 1.34p

Genedrive Key Personnel

CFO Russell Shaw
CEO Gino Miele

Top of Page